This node is now inactive. (Merged with the California-Arizona Node to form the Western States Node in 2010)
The Oregon-Hawaii Node is a bi-directional clinical trial partnership of two research and training organizations -- Oregon Health & Science University with support from the Kaiser Permanente Center for Health Research in Honolulu, Hawaii -- and multi-modality drug treatment programs located in urban and rural communities in Oregon, Hawaii, and Oklahoma. These programs serve a growing number of Latino, Native American, Hawaiian, Russian, Asian, and female clients. Services are provided across the treatment continuum.
- HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S. (CTN-0032)
- Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement (CTN-0031)
- Prescription Opioid Addiction Treatment Study (POATS) (CTN-0030)
- A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD) (CTN-0029)
- Starting Treatment with Agonist Replacement Therapies (START) Study (CTN-0027)
- Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse (CTN-0021)
- Job-Seekers Training for Patients with Drug Dependence (CTN-0020)
- HIV and HCV Intervention in Drug Treatment Settings (CTN-0017)
- Motivational Interviewing (MI) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0005)
- Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules (CTN-0003)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Outpatient Opiate Detoxification (CTN-0002)
Get this Publication
Formed with SAMHSA to reduce the gap between research results and treatment.